Bodycote Takeover Saga Nears Finish Line as CVC Steps Aside

CVC confirms no Bodycote offer under Rule 2.8, leaving Veritas as sole bidder at 940p per share; shareholder vote set for 21 October 2026.

Bodycote shareholders now know exactly what is on the table — and what is not. CVC Advisers confirmed today that it will not table an offer for the British heat-treatment specialist, formally invoking Rule 2.8 of the UK Takeover Code. The declaration leaves Vulcan Alpha Bidco, the vehicle controlled by Veritas Capital, as the sole bidder for the company.

The announcement draws a line under a contest that had once looked far more crowded. Back in August, Veritas and CVC were locked in a tight bidding duel, with CVC floating up to 915 pence per share against Veritas's 914 pence. Before that, Apollo had already walked away in June after proposing a deal valued at GBP 1.52 billion. With CVC's exit, the market's bet on a sweetened price has evaporated.

Shares Slip as Bidding Premium Unwinds

Equity in Bodycote fell on the news. The stock shed 3.1% to GBP 9.17 in today's session, reflecting the disappearance of any residual hope for a higher counterbid. CVC left itself a narrow door back into the process, but only under exceptional circumstances: a fresh offer would be considered solely if the current bid lapses, a new third party submits a binding proposal, or regulators identify a material change in circumstances.

What Veritas Is Paying

The Veritas offer is worth a total of 940 pence per share, comprising 932.8 pence in cash plus an interim dividend of 7.2 pence per share for the 2026 financial year. The deal values Bodycote's equity at roughly GBP 1.64 billion, with an enterprise value including debt of about GBP 1.85 billion. Reuters pegs the transaction at approximately USD 2.5 billion.

Bodycote's board has thrown its weight behind the proposal unanimously and recommends that shareholders accept the cash offer. Directors have also committed irrevocably to vote in favour of the arrangement.

Scheme Document Published, Vote Set for 21 October

Alongside the resolution of the bidding field, Bodycote released its formal takeover circular today. The transaction will be executed through a court-sanctioned scheme of arrangement under Part 26 of the UK Companies Act. Shareholders will cast their votes on Wednesday, 21 October 2026.

Approval requires a dual majority: a simple majority in number of participating shareholders, plus at least 75% of the voting share capital. The deal also needs formal court approval. Assuming all conditions are met, the acquisition is expected to become effective in the first quarter of 2027, after which Bodycote plans to delist from the London Stock Exchange.

JPMorgan Crosses Voting Threshold

Amid the takeover mechanics, institutional holdings have been shifting. JPMorgan Chase & Co. disclosed last Wednesday that it had crossed the notification threshold as of 21 September. The US bank now holds 5.190785% of Bodycote's voting rights in total, with the bulk of that position represented through financial instruments.

Business Continues to Expand Despite Bid

The takeover process has not halted Bodycote's operational momentum. On 22 September, the company announced investments exceeding USD 30 million at its Fairfield and London sites in Ohio. About USD 12 million is earmarked for relocating and expanding the Fairfield facility, while roughly USD 20 million will fund a new large-scale hot isostatic pressing (HIP) plant in London, scheduled to be operational from October 2026.

There have also been changes at board level. On Thursday, Non-Executive Director Emmanuelle Dubu took over as chair of the remuneration committee, succeeding Cynthia Gordon, who stepped down from her mandate on 23 September. The governance transition proceeds in orderly fashion as the Veritas acquisition enters its final stretch.